National Healthcare Corp. (NHC)
ROE
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 66 798 | 44 745 | 31 928 | 18 850 | 22 445 | 31 880 | 30 961 | 132 641 |
| Kapitał własny | w tys. USD | 908 752 | 885 171 | 883 922 | 877 102 | 874 276 | 877 311 | 897 915 | 905 319 |
| ROE | 7,35% | 5,05% | 3,61% | 2,15% | 2,57% | 3,63% | 3,45% | 14,65% |
2023/Q4 obliczenia
ROE = Zysk netto (ttm) ÷ Kapitał własny
= $66 798K ÷ $908 752K
= 7,35%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROE
National Healthcare Corp.
NHC
7,35%
Acadia Healthcare Company Inc
ACHC
-0,78%
Encompass Health Corp
EHC
21,22%
Ensign Group Inc
ENSG
14,04%
HCA Healthcare Inc
HCA
—
Pediatrix Medical Group Inc
MD
-7,11%
Select Medical Holdings Corporation
SEM
18,22%
Tenet Healthcare Corp.
THC
38,00%
Universal Health Services, Inc.
UHS
11,67%